Differential activation of nuclear transcription factor κB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells

Seminars in Radiation Oncology

Volumn 12, Issue 1 SUPPL. 1, 2002, Pages 103-111

  Grdina, David J ^a,b   Murley, Jeffrey S ^a,b   Kataoka, Yasushi ^a,b   Calvin, Douglas P ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; AMIFOSTINE; BASIC FIBROBLAST GROWTH FACTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MANGANESE SUPEROXIDE DISMUTASE; PADGEM PROTEIN; PROTEIN P50; PROTEIN P52; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR REL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

CELL PROTECTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLIOMA CELL; HUMAN; HUMAN CELL; MICROVASCULATURE; PRIORITY JOURNAL; TIME; TRANSCRIPTION INITIATION; VASCULAR ENDOTHELIUM;

EID: 0036127988     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2002.31383     Document Type: Conference Paper

References (27)

1. Chemopreventive activity of oltipraz
2. American Society of Clinical Oncology clinical practice guidelines for the use of chemotherapy and radiotherapy protectants
3. Amifostine and hematologic effects
4. Redox regulation of NT-kappa B activation
5. WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase IIα leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells
6. Antioxidant and redox regulation of gene transcription
7. Activation of NF-κB and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells
8. Oltipraz stimulates the transcription of the manganese superoxide dismutase gene in rat hepatocytes
9. Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-κB/Rel transcription factors
10. Activation of NFκB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells
11. Function and activation of NF-κB in the immune system
12. Activators and target genes of Rel/NFκB transcription factors
13. Activation of HIV gene expression during monocyte differentiation by induction of NFκB
14. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate
15. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for accelerated vasculopathy of diabetes
16. Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase
17. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules
18. Activation of NF-κB by antineoplastic agents
19. Invited review: Manganese superoxide dismutase in disease
20. Transfection and expression of MnSOD cDNA decreases tumor malignancy of human oral squamous carcinoma SCC-25 cells
21. Overexpression of manganese superoxide dismutase in DU 145 human prostate carcinoma cells has multiple effects on cell phenotype
22. Cytoprotection by WR1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines
23. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
24. In vivo effects of IL-4, IL-10, and amifostine on cytokine production in patients with myelogenous leukemia
25. The effect of the radioprotector WR-2721 and WR-1065 on mitochondrial lipid peroxidation
26. Protective effects of the thiophosphate amifostine (WR 2721) and a lazaroid (U83836E) on lipid peroxidation in endothelial cells during hypoxia/reoxygenation
27. 4 decrease experimental colitis